Skip to content

A study to compare the effect of two Ayurvedic medicines Phaltrikadi Ghan Vati and Tryushn Churna in the management of high cholesterol

Randomized comparative clinical study to evaluate the efficacy of Phaltrikadi Ghan Vati and Tryushn Churna in the management of Medorga(Dyslipidemia) - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107166
Enrollment
46
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Post Graduate Institute of Ayurved Jodhpur Rajasthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ) Patients age between 20-70 years of either both of sex. 2) Diagnosed cases of Dyslipidemia & Medoroga on the basis of criteria given (Serum Cholesterol greater than and equal 200 mg/dl + Total Cholesterol,HDL ratio greater than 4.5) 3) Patients having Clinical signs and symptoms due to Dyslipidaemia.

Exclusion criteria

Exclusion criteria: ) Age below 20 years and above than 70 years 2) Patients with serious cardiovascular conditions such as unstable angina, recent myocardial infarction, uncontrolled hypertension (diastolic BP greater than 100 mmHg), or poorly managed diabetes mellitus. 3) Individuals with compromised kidney function, indicated by serum creatinine levels equal to or exceeding 2 mg/dL. 4) Patients diagnosed with or suspected of having any form of malignancy and other lifethreatening condition. 5) Pregnant or breastfeeding women, as well as individuals whose dyslipidemia is druginduced (e.g., due to glucocorticoids, diuretics, etc.). 6) Heavy drinkers and drug abusers. Withdrawal Criteria: 1) During the course of trial if any serious condition or any serious adverse effect occurs

Design outcomes

Primary

MeasureTime frame
1) Reduction in the level of Serum Triglycerides and Serum LDL. 2) Increase in Serum HDL levelTimepoint: 60 days after treatment.

Secondary

MeasureTime frame
1) Reduction in weight 2) Reduction in Apolipoprotein B. 3) Qualitative improvement in lifestyle changesTimepoint: 60 days after treatment.

Countries

India

Contacts

Public ContactDr shanu palaria

Post Graduate Institute Of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved university Jodhpur rajasthan

bkmudgal9@gmail.com9460318138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026